View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. Noble Life Sciences
6 March 2019

Visit Noble Life Sciences at Society of Toxicology

Noble Life Sciences will be exhibiting at this year’s Society of Toxicology taking place in Baltimore, Maryland, US.

The company will be featuring its services and the benefits of working with Noble.

Some of Noble Life Sciences’ toxicology services include:

  • Dose range finding
  • Single and repeat dose
  • Acute, subchronic and chronic
  • Local tolerance
  • Biodistribution
  • Ocular and skin irritation evaluation
  • Maximum tolerated dose (MTD)

To learn more about these services or schedule a meeting with the company, send an enquiry using the form on this page. You can also stop by Booth 4284 anytime during the show.

Service spotlight

Noble Life Sciences has optimised an STZ-induced diabetes rat model. This is the model of choice for preclinical development of therapeutic agents for diabetes because:

  • The STZ-induced diabetes model in rats has been extensively studied and characterised
  • This is a simple and relatively cost-effective model of diabetes
  • STZ causes complete eradication of pancreas beta cells when administered at a single high dose and can thus be used as a model for Type 1 diabetes where insulin production is absent

Applications include:

  • Diabetes treatment/management development for lowering blood glucose in a non-beta-cell-dependent manner
  • Testing transplantation therapies where the endpoint is lowering of blood glucose
  • Diabetes pathophysiology
  • Study of diabetes side effects

Type 1 diabetes is an autoimmune disorder that affects nearly 347 million people worldwide.
Implantable continuous infusion osmotic pumps have several applications in preclinical drug development.
NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy


Thank you for subscribing to Medical Device Network